Table 1.
Tissue source | Patient ID | All somatic variants |
Somatic driver variants |
||||
---|---|---|---|---|---|---|---|
UTR3 | UTR5 | Exonic | UTR3 | UTR5 | Exonic | ||
Tumor tissue | P1 | 2,217 | 365 | 13 | 103 | 18 | 2 |
P2 | 2,488 | 426 | 13 | 127 | 23 | 0 | |
P4 | 2,238 | 439 | 7 | 95 | 20 | 0 | |
P5 | 2,589 | 453 | 13 | 130 | 22 | 0 | |
P6 | 2,141 | 419 | 6 | 88 | 17 | 0 | |
Urine exosomes | P1 | 3,442 | 470 | 25 | 188 | 28 | 1 |
P2 | 2,189 | 345 | 25 | 105 | 22 | 2 | |
P4 | 287 | 75 | 93 | 7 | 4 | 3 | |
P5 | 1,215 | 192 | 23 | 85 | 4 | 3 | |
P6 | 1,229 | 172 | 30 | 55 | 11 | 2 | |
Serum exosomes | P1 | 118 | 44 | 62 | 5 | 5 | 1 |
P2 | 1,047 | 175 | 62 | 72 | 16 | 1 | |
P4 | 460 | 141 | 68 | 19 | 5 | 4 | |
P5 | 766 | 142 | 8 | 57 | 11 | 1 | |
P6 | 150 | 48 | 52 | 6 | 3 | 2 |
In the discovery-based approach, somatic variants in all samples were identified by filtering against all variants found in the normal tissue (PBMC) sequence, followed by using the minor allelic frequency (MAF) test. P1–P6, patients 1–6.